The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...
People will be able to carry a list of their current medications in the first HSE app that is due to be available to download in March. The app, which will have limited functions initially, will ...